Less than one in four women who seek care for perimenopause symptoms receive adequate advice and treatment.
That's not a statistic I'm citing to be alarming — it's from research published in Menopause, the journal of the Menopause Society, and it reflects something most women in their 40s will recognize from personal experience: the medical system frequently fails this transition.
Women describe symptoms to their doctors, are told it's stress, anxiety, or depression, and leave without the word "perimenopause" ever being used. Symptoms begin years — sometimes a decade — before the final menstrual period. Many clinicians are still taught to think of menopause as a late-40s event when periods stop. Perimenopause is frequently invisible in that framework.
The Symptoms That Get Missed Most Often
Cognitive Changes
Word-finding difficulty, attention fragmentation, memory gaps. These are documented neurological effects of estrogen fluctuation, not personality changes or anxiety. University of Rochester research found measurable differences in cognitive testing in women during the menopausal transition compared to pre-menopausal baselines.
Sleep Disruption Without Obvious Cause
Women describe waking at 2 or 3am in a state of alertness that isn't anxiety. This is progesterone withdrawal affecting GABA pathways — the same pathway sleep medications target. It rarely gets a hormonal explanation in primary care.
Joint Pain and Stiffness
Estrogen is anti-inflammatory. Its decline removes a systemic protective effect. Joints — particularly hands and knees — often become symptomatic in perimenopause in ways that look like early arthritis and frequently get sent to rheumatology without a hormonal workup.
Heart Palpitations
Estrogen affects cardiac electrical conduction. Palpitations are common in perimenopause and are often referred to cardiology without the hormonal question being asked first.
Changes in Anxiety Baseline
Women who managed anxiety well for years describe a new intensity that begins without obvious life triggers. The hormonal connection is rarely made in clinical settings.
What Women Are Actually Doing About It
Options vary by symptom severity, personal preference, and access. Hormone therapy — when appropriate and prescribed competently — remains the most effective intervention for vasomotor symptoms. It's more evidence-backed and safer than public perception has suggested since the 2002 WHI study's initial and later-corrected interpretation.
Botanical options have genuine clinical data behind several compounds: Black Cohosh, Red Clover isoflavones, and Chasteberry all have meaningful research in peer-reviewed literature. Not as strong as HRT for severe symptoms — but real for mild to moderate presentations.
The most important step is often not finding the right supplement. It's finding a clinician who takes the transition seriously.
Mendi Balance combines 8 clinically-studied botanicals — including 160mg Black Cohosh and 400mg Red Clover — at the doses used in the research. Not trace amounts.
References:
Shifren & Gass, Menopause 2014 — NAMS Recommendations
Weber et al., Menopause 2013 — Cognitive Changes During Transition
Leach & Moore, Cochrane Database 2012 — Black Cohosh for Menopausal Symptoms